Spontaneous Tumor Models

Spontaneous Tumor Models

Spontaneous tumor models are invaluable tools in cancer research, as they closely mimic the natural development and progression of human cancers. Unlike transplanted tumor models, spontaneous tumor models arise from genetic alterations within the organism, providing insights into tumor initiation, progression, and metastasis in an immunocompetent environment. These models are particularly useful for studying the complex interactions between tumors and the immune system, as well as for evaluating the efficacy of anticancer therapies in a setting that closely resembles human physiology.

We have a collection of spontaneous tumor mouse models targeting four major cancer types frequently observed in humans: pancreatic cancer, hepatobiliary cancer, breast cancer, and colorectal carcinoma.

Strain No.Strain NameStrain TypeTypeDescription
T017650Kras-KOKras KnockoutLungKnockout of the KRAS gene to study KRAS-related signaling pathways and diseases.
T015831B6-KPKras and Trp53 double conditional point mutationDependent on Cre lineUsed for screening anti-tumor medications targeting KrasG12D and p53R172H; applicable in liver, lung, and pancreatic cancer research.
T015831B6-KPCB6-KP + Pdx1 CrePancreaticKras and Trp53 double conditional point mutation with Pdx1-Cre
T009879Rosa26-CAG-LSL-hMYC-polyAhMYC conditional knockinHepatobiliary cancer in the presence of Alb-CreOffspring of B6-AlbCre mice develop hepatocellular carcinoma at 10 weeks, suitable for anti-tumor medicine screening.
T007671B6-p53 R172HTrp53 conditional point mutationDependent on Cre lineIntroduces a point mutation in p53 gene codon 172; used to study various cancers and for small molecule drug screening.
T007256Kras-floxTrp53 conditional knockoutLungAllows conditional knockout of the KRAS gene in specific tissues; used to study KRAS-related signaling pathways.
T005480Trp53-floxTrp53 conditional point mutationDependent on Cre lineUsed to study the genesis and progression of malignancies caused by the p53 gene.
T005332B6-p53-KOTrp53 knockoutMultiple tumorsDevelops lymphoma and sarcoma at 3–6 months; used to study multiple cancers and for small molecule drug screening.
T004993FVB-MMTV-PyMTMMPV-PyMT random transgeneBreastSpontaneous breast cancer model; used for anti-breast cancer drug screening and research.
T004551B6-Kras-LSL-G12DKras G12D conditional point mutationDependent on Cre lineIntroduces a point mutation in Kras gene codon 12; used for research on various cancers and for small molecule drug screening.
T001457APC-minAPC point mutationColorectalSpontaneous colon cancer model; used for small molecule drug screening for gut tumors and GI tract tumor/adenoma studies.

Contact us today for expert support in animal models and preclinical services.